Skip to main content

Cancer's "Moonshot"

Premium

Ron DePinho, the new president of the MD Anderson Cancer Center in Houston, hopes to cure five types of cancer — a feat that DePinho acknowledges is a "moonshot," reports The Economist. Which five cancers to tackle hasn't been decided yet, but The Economist says that the effort would only be possible because of the International Cancer Genome Consortium, which is working to thoroughly sequence the genomes of 50 cancer types. At MD Anderson, DePinho wants to "'industrialize' other aspects of biological research in the way that genetics has been pushed forward by high-throughput sequencing," The Economist says.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.